Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Spastic hypertonia is common after stroke. Whole-body vibration (WBV) is known to have modulatory effects of muscle reflex activity and blood flow in other populations and thus have potential applications in the management of spastic hypertonia post-stroke. This study aims to investigate the acute effect of WBV on leg muscle H-reflex, stiffness, and blood perfusion in people with chronic stroke.
Spastic hypertonia is common after stroke. Whole-body vibration (WBV) is known to have modulatory effects of muscle reflex activity and blood flow in other populations and thus have potential applications in management of spastic hypertonia post-stroke. However, the potential effects of WBV on leg muscle stiffness in stroke rehabilitation remains unknown. Scientific evidence is warranted to fill the knowledge gap.
Purpose This study aims to investigate the acute effect of WBV on leg muscle H-reflex, stiffness and blood perfusion in people with chronic stroke.
Methods Individuals with chronic stroke will be recruited from community self-help groups and existing patient database. Relevant information (e.g. demographic information, medical history) will be obtained from medical records and subject interviews. Each subject will have to fulfill the following inclusion criteria: (1) diagnosis of chronic stroke, (2) community-dwelling, (3) able to follow simple verbal instructions. Exclusion criteria are: (1) other diagnoses of neurological conditions, (2) significant musculoskeletal conditions (e.g. amputations), (3) metal implants in the lower extremity or spine, (4) recent fracture in the lower extremity, (5) diagnosis of osteoporosis, (6) vestibular disorders, (7) peripheral vascular disease, and (11) other serious illnesses or contraindications to exercise.
This is a single-blinded randomized within-patient cross-over study. Each participant was evaluated for the soleus H-reflex, stiffness and blood perfusion of the medial gastrocnemius (MG) using ultrasound on both sides before and after either a 5-minute WBV intervention (30 Hertz, 1.5mm, knee flexed 60 degrees) or a no-WBV condition (5 minutes). The measurements were performed at baseline and every 1-min post-intervention up to 5 minutes. The outcomes generated included the soleus H/M ratio, shear modulus and vascular index (VI) of the MG muscle.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Control | Active Comparator | This group will stand with knee flexion 60 degrees on the same vibration platform for 60 seconds for 5 times with 60-seconds rest interval, but no vibration will be given. |
|
| High intensity whole body vibration | Active Comparator | This group will stand with knee flexion 60 degrees on the same vibration platform for 60 seconds for 5 times with 60-seconds rest interval. The whole body vibration platform will be set with frequency at 30Hz and amplitude at 1.5mm. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| paretic leg-control | Device | standing on the vibration platform, with no vibration signals delivered. |
|
| Measure | Description | Time Frame |
|---|---|---|
| H-reflex of paretic soleus muscle | To measure the efficacy of synaptic transmission | Immediately before the intervention |
| H-reflex of paretic soleus muscle | To measure the efficacy of synaptic transmission | 1st minute after the intervention |
| H-reflex of paretic soleus muscle | To measure the efficacy of synaptic transmission | 2nd minute after the intervention |
| H-reflex of paretic soleus muscle | To measure the efficacy of synaptic transmission | 3rd minute after the intervention |
| H-reflex of paretic soleus muscle | To measure the efficacy of synaptic transmission | 4th minute after the intervention |
| H-reflex of paretic soleus muscle | To measure the efficacy of synaptic transmission | 5th minute after the intervention |
| Muscle stiffness of paretic medial gastrocnemius | Measured by Supersonic elastography with ankle in neutral position | Immediately before the intervention |
| Muscle stiffness of paretic medial gastrocnemius | Measured by Supersonic elastography with ankle in neutral position |
| Measure | Description | Time Frame |
|---|---|---|
| Intramuscular blood perfusion of paretic medial gastrocnemius muscle | Measured by power Doppler ultrasound | Immediately before the intervention |
| Intramuscular blood perfusion of paretic medial gastrocnemius muscle |
| Measure | Description | Time Frame |
|---|---|---|
| Fugl-Meyer Assessment of Motor Recovery after Stroke--lower extremities | Evaluates and measures motor recovery in post-stroke hemiplegic patients | Immediately before the intervention |
| Brief Balance Evaluation Systems Test |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Hector WH Tsang, PhD | Department of Rehabilitation Sciences, The Hong Kong Polytechnic University | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| The Hong Kong Polytechnic University | Hung Hom | Kowloon | Hong Kong |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D020521 | Stroke |
| ID | Term |
|---|---|
| D002561 | Cerebrovascular Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| paretic leg-WBV | Device | standing on the vibration platform, with WBV at 30Hz, 1.5mm. |
|
| non-paretic leg-control | Device | standing on the vibration platform, with no vibration signals delivered. |
|
| non-paretic leg-WBV | Device | standing on the vibration platform, with WBV at 30Hz, 1.5mm. |
|
| 1st minute after the intervention |
| Muscle stiffness of paretic medial gastrocnemius | Measured by Supersonic elastography with ankle in neutral position | 2nd minute after the intervention |
| Muscle stiffness of paretic medial gastrocnemius | Measured by Supersonic elastography with ankle in neutral position | 3rd minute after the intervention |
| Muscle stiffness of paretic medial gastrocnemius | Measured by Supersonic elastography with ankle in neutral position | 4th minute after the intervention |
| Muscle stiffness of paretic medial gastrocnemius | Measured by Supersonic elastography with ankle in neutral position | 5th minute after the intervention |
| H-reflex of non-paretic soleus muscle | To measure the efficacy of synaptic transmission | Immediately before the intervention |
| H-reflex of non-paretic soleus muscle | To measure the efficacy of synaptic transmission | 1st minute after the intervention |
| H-reflex of non-paretic soleus muscle | To measure the efficacy of synaptic transmission | 2nd minute after the intervention |
| H-reflex of non-paretic soleus muscle | To measure the efficacy of synaptic transmission | 3rd minute after the intervention |
| H-reflex of non-paretic soleus muscle | To measure the efficacy of synaptic transmission | 4th minute after the intervention |
| H-reflex of non-paretic soleus muscle | To measure the efficacy of synaptic transmission | 5th minute after the intervention |
| Muscle stiffness of non-paretic medial gastrocnemius | Measured by Supersonic elastography with ankle in neutral position | Immediately before the intervention |
| Muscle stiffness of non-paretic medial gastrocnemius | Measured by Supersonic elastography with ankle in neutral position | 1st minute after the intervention |
| Muscle stiffness of non-paretic medial gastrocnemius | Measured by Supersonic elastography with ankle in neutral position | 2nd minute after the intervention |
| Muscle stiffness of non-paretic medial gastrocnemius | Measured by Supersonic elastography with ankle in neutral position | 3th minute after the intervention |
| Muscle stiffness of non-paretic medial gastrocnemius | Measured by Supersonic elastography with ankle in neutral position | 4th minute after the intervention |
| Muscle stiffness of non-paretic medial gastrocnemius | Measured by Supersonic elastography with ankle in neutral position | 5th minute after the intervention |
Measured by power Doppler ultrasound
| 1 minute after the intervention |
| Intramuscular blood perfusion of paretic medial gastrocnemius muscle | Measured by power Doppler ultrasound | 2nd minute after the intervention |
| Intramuscular blood perfusion of paretic medial gastrocnemius muscle | Measured by power Doppler ultrasound | 3rd minute after the intervention |
| Intramuscular blood perfusion of paretic medial gastrocnemius muscle | Measured by power Doppler ultrasound | 4th minute after the intervention |
| Intramuscular blood perfusion of paretic medial gastrocnemius muscle | Measured by power Doppler ultrasound | 5th minute after the intervention |
| Intramuscular blood perfusion of non-paretic medial gastrocnemius muscle | Measured by power Doppler ultrasound | Immediately before the intervention |
| Intramuscular blood perfusion of non-paretic medial gastrocnemius muscle | Measured by power Doppler ultrasound | 1th minute after the intervention |
| Intramuscular blood perfusion of non-paretic medial gastrocnemius muscle | Measured by power Doppler ultrasound | 2nd minute after the intervention |
| Intramuscular blood perfusion of non-paretic medial gastrocnemius muscle | Measured by power Doppler ultrasound | 3rd minute after the intervention |
| MoviIntramuscular blood perfusion of non-paretic medial gastrocnemius muscle | Measured by power Doppler ultrasound | 4th minute after the intervention |
| Intramuscular blood perfusion of non-paretic medial gastrocnemius muscle | Measured by power Doppler ultrasound | 5th minute after the intervention |
| Immediately before the intervention |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |